Pain Relief Patches Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
SUMMARY
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Pain Relief Patches market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Pain Relief Patches market segmented into
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Pain Relief Patches market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Pain Relief Patches market segmented into
- OTC
- Diclofenac Patches
- Indomethacin Patches
- Counter-Irritant Patches
- Fentanyl Patches
- Others
- OTC
- Rx
- North America [U.S., Canada, Mexico]
- Europe [Germany, UK, France, Italy, Rest of Europe]
- Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
- South America [Brazil, Argentina, Rest of Latin America]
- Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
- Hisamitsu
- Mylan
- Johnson & Johnson
- Actavis
- Lingrui
- Teikoku Seiyaku
- Sanofi
- Novartis
- Qizheng
- Endo
- Huarun 999
- GSK
- Haw Par
- Nichiban
- Mentholatum Company
- Laboratoires Genevrier
- BLUE-EMU
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL PAIN RELIEF PATCHES INDUSTRY
2.1 Summary about Pain Relief Patches Industry
2.2 Pain Relief Patches Market Trends
2.2.1 Pain Relief Patches Production & Consumption Trends
2.2.2 Pain Relief Patches Demand Structure Trends
2.3 Pain Relief Patches Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Lidocaine Patches
4.2.2 Diclofenac Patches
4.2.3 Indomethacin Patches
4.2.4 Counter-Irritant Patches
4.2.5 Fentanyl Patches
4.2.6 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 OTC
4.3.2 Rx
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Lidocaine Patches
5.2.2 Diclofenac Patches
5.2.3 Indomethacin Patches
5.2.4 Counter-Irritant Patches
5.2.5 Fentanyl Patches
5.2.6 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 OTC
5.3.2 Rx
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Lidocaine Patches
6.2.2 Diclofenac Patches
6.2.3 Indomethacin Patches
6.2.4 Counter-Irritant Patches
6.2.5 Fentanyl Patches
6.2.6 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 OTC
6.3.2 Rx
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Lidocaine Patches
7.2.2 Diclofenac Patches
7.2.3 Indomethacin Patches
7.2.4 Counter-Irritant Patches
7.2.5 Fentanyl Patches
7.2.6 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 OTC
7.3.2 Rx
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Lidocaine Patches
8.2.2 Diclofenac Patches
8.2.3 Indomethacin Patches
8.2.4 Counter-Irritant Patches
8.2.5 Fentanyl Patches
8.2.6 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 OTC
8.3.2 Rx
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Lidocaine Patches
9.2.2 Diclofenac Patches
9.2.3 Indomethacin Patches
9.2.4 Counter-Irritant Patches
9.2.5 Fentanyl Patches
9.2.6 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 OTC
9.3.2 Rx
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Hisamitsu
10.1.2 Mylan
10.1.3 Johnson & Johnson
10.1.4 Actavis
10.1.5 Lingrui
10.1.6 Teikoku Seiyaku
10.1.7 Sanofi
10.1.8 Novartis
10.1.9 Qizheng
10.1.10 Endo
10.1.11 Huarun
10.1.12 GSK
10.1.13 Haw Par
10.1.14 Nichiban
10.1.15 Mentholatum Company
10.1.16 Laboratoires Genevrier
10.1.17 BLUE-EMU
10.2 Pain Relief Patches Sales Date of Major Players (2017-2020e)
10.2.1 Hisamitsu
10.2.2 Mylan
10.2.3 Johnson & Johnson
10.2.4 Actavis
10.2.5 Lingrui
10.2.6 Teikoku Seiyaku
10.2.7 Sanofi
10.2.8 Novartis
10.2.9 Qizheng
10.2.10 Endo
10.2.11 Huarun
10.2.12 GSK
10.2.13 Haw Par
10.2.14 Nichiban
10.2.15 Mentholatum Company
10.2.16 Laboratoires Genevrier
10.2.17 BLUE-EMU
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL PAIN RELIEF PATCHES INDUSTRY
2.1 Summary about Pain Relief Patches Industry
2.2 Pain Relief Patches Market Trends
2.2.1 Pain Relief Patches Production & Consumption Trends
2.2.2 Pain Relief Patches Demand Structure Trends
2.3 Pain Relief Patches Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Lidocaine Patches
4.2.2 Diclofenac Patches
4.2.3 Indomethacin Patches
4.2.4 Counter-Irritant Patches
4.2.5 Fentanyl Patches
4.2.6 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 OTC
4.3.2 Rx
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Lidocaine Patches
5.2.2 Diclofenac Patches
5.2.3 Indomethacin Patches
5.2.4 Counter-Irritant Patches
5.2.5 Fentanyl Patches
5.2.6 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 OTC
5.3.2 Rx
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Lidocaine Patches
6.2.2 Diclofenac Patches
6.2.3 Indomethacin Patches
6.2.4 Counter-Irritant Patches
6.2.5 Fentanyl Patches
6.2.6 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 OTC
6.3.2 Rx
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Lidocaine Patches
7.2.2 Diclofenac Patches
7.2.3 Indomethacin Patches
7.2.4 Counter-Irritant Patches
7.2.5 Fentanyl Patches
7.2.6 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 OTC
7.3.2 Rx
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Lidocaine Patches
8.2.2 Diclofenac Patches
8.2.3 Indomethacin Patches
8.2.4 Counter-Irritant Patches
8.2.5 Fentanyl Patches
8.2.6 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 OTC
8.3.2 Rx
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Lidocaine Patches
9.2.2 Diclofenac Patches
9.2.3 Indomethacin Patches
9.2.4 Counter-Irritant Patches
9.2.5 Fentanyl Patches
9.2.6 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 OTC
9.3.2 Rx
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Hisamitsu
10.1.2 Mylan
10.1.3 Johnson & Johnson
10.1.4 Actavis
10.1.5 Lingrui
10.1.6 Teikoku Seiyaku
10.1.7 Sanofi
10.1.8 Novartis
10.1.9 Qizheng
10.1.10 Endo
10.1.11 Huarun
10.1.12 GSK
10.1.13 Haw Par
10.1.14 Nichiban
10.1.15 Mentholatum Company
10.1.16 Laboratoires Genevrier
10.1.17 BLUE-EMU
10.2 Pain Relief Patches Sales Date of Major Players (2017-2020e)
10.2.1 Hisamitsu
10.2.2 Mylan
10.2.3 Johnson & Johnson
10.2.4 Actavis
10.2.5 Lingrui
10.2.6 Teikoku Seiyaku
10.2.7 Sanofi
10.2.8 Novartis
10.2.9 Qizheng
10.2.10 Endo
10.2.11 Huarun
10.2.12 GSK
10.2.13 Haw Par
10.2.14 Nichiban
10.2.15 Mentholatum Company
10.2.16 Laboratoires Genevrier
10.2.17 BLUE-EMU
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
LIST OF TABLES
1.Table Pain Relief Patches Product Type Overview
2.Table Pain Relief Patches Product Type Market Share List
3.Table Pain Relief Patches Product Type of Major Players
4.Table Brief Introduction of Hisamitsu
5.Table Brief Introduction of Mylan
6.Table Brief Introduction of Johnson & Johnson
7.Table Brief Introduction of Actavis
8.Table Brief Introduction of Lingrui
9.Table Brief Introduction of Teikoku Seiyaku
10.Table Brief Introduction of Sanofi
11.Table Brief Introduction of Novartis
12.Table Brief Introduction of Qizheng
13.Table Brief Introduction of Endo
14.Table Brief Introduction of Huarun 999
15.Table Brief Introduction of GSK
16.Table Brief Introduction of Haw Par
17.Table Brief Introduction of Nichiban
18.Table Brief Introduction of Mentholatum Company
19.Table Brief Introduction of Laboratoires Genevrier
20.Table Brief Introduction of BLUE-EMU
21.Table Products & Services of Hisamitsu
22.Table Products & Services of Mylan
23.Table Products & Services of Johnson & Johnson
24.Table Products & Services of Actavis
25.Table Products & Services of Lingrui
26.Table Products & Services of Teikoku Seiyaku
27.Table Products & Services of Sanofi
28.Table Products & Services of Novartis
29.Table Products & Services of Qizheng
30.Table Products & Services of Endo
31.Table Products & Services of Huarun 999
32.Table Products & Services of GSK
33.Table Products & Services of Haw Par
34.Table Products & Services of Nichiban
35.Table Products & Services of Mentholatum Company
36.Table Products & Services of Laboratoires Genevrier
37.Table Products & Services of BLUE-EMU
38.Table Market Distribution of Major Players
39.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
40.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
41.Table Global Pain Relief Patches Market Forecast (Million USD) by Region 2021f-2026f
42.Table Global Pain Relief Patches Market Forecast (Million USD) Share by Region 2021f-2026f
43.Table Global Pain Relief Patches Market Forecast (Million USD) by Demand 2021f-2026f
44.Table Global Pain Relief Patches Market Forecast (Million USD) Share by Demand 2021f-2026f
1.Table Pain Relief Patches Product Type Overview
2.Table Pain Relief Patches Product Type Market Share List
3.Table Pain Relief Patches Product Type of Major Players
4.Table Brief Introduction of Hisamitsu
5.Table Brief Introduction of Mylan
6.Table Brief Introduction of Johnson & Johnson
7.Table Brief Introduction of Actavis
8.Table Brief Introduction of Lingrui
9.Table Brief Introduction of Teikoku Seiyaku
10.Table Brief Introduction of Sanofi
11.Table Brief Introduction of Novartis
12.Table Brief Introduction of Qizheng
13.Table Brief Introduction of Endo
14.Table Brief Introduction of Huarun 999
15.Table Brief Introduction of GSK
16.Table Brief Introduction of Haw Par
17.Table Brief Introduction of Nichiban
18.Table Brief Introduction of Mentholatum Company
19.Table Brief Introduction of Laboratoires Genevrier
20.Table Brief Introduction of BLUE-EMU
21.Table Products & Services of Hisamitsu
22.Table Products & Services of Mylan
23.Table Products & Services of Johnson & Johnson
24.Table Products & Services of Actavis
25.Table Products & Services of Lingrui
26.Table Products & Services of Teikoku Seiyaku
27.Table Products & Services of Sanofi
28.Table Products & Services of Novartis
29.Table Products & Services of Qizheng
30.Table Products & Services of Endo
31.Table Products & Services of Huarun 999
32.Table Products & Services of GSK
33.Table Products & Services of Haw Par
34.Table Products & Services of Nichiban
35.Table Products & Services of Mentholatum Company
36.Table Products & Services of Laboratoires Genevrier
37.Table Products & Services of BLUE-EMU
38.Table Market Distribution of Major Players
39.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
40.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
41.Table Global Pain Relief Patches Market Forecast (Million USD) by Region 2021f-2026f
42.Table Global Pain Relief Patches Market Forecast (Million USD) Share by Region 2021f-2026f
43.Table Global Pain Relief Patches Market Forecast (Million USD) by Demand 2021f-2026f
44.Table Global Pain Relief Patches Market Forecast (Million USD) Share by Demand 2021f-2026f
LIST OF FIGURES
1.Figure Global Pain Relief Patches Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Pain Relief Patches Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Pain Relief Patches Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Pain Relief Patches Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Pain Relief Patches Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Pain Relief Patches Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Pain Relief Patches Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Lidocaine Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Diclofenac Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Indomethacin Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Counter-Irritant Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Fentanyl Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure OTC Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Rx Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Lidocaine Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Diclofenac Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Indomethacin Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Counter-Irritant Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Fentanyl Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure OTC Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Rx Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Lidocaine Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Diclofenac Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure Indomethacin Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Counter-Irritant Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Fentanyl Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure OTC Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Rx Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Lidocaine Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Diclofenac Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Indomethacin Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Counter-Irritant Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Fentanyl Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure OTC Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Rx Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Lidocaine Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Diclofenac Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Indomethacin Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Counter-Irritant Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Fentanyl Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure OTC Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Rx Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
72.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
73.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
74.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY)
1.Figure Global Pain Relief Patches Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Pain Relief Patches Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Pain Relief Patches Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Pain Relief Patches Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Pain Relief Patches Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Pain Relief Patches Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Pain Relief Patches Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Lidocaine Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Diclofenac Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Indomethacin Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Counter-Irritant Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Fentanyl Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure OTC Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Rx Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Lidocaine Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Diclofenac Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Indomethacin Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Counter-Irritant Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Fentanyl Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure OTC Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Rx Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Lidocaine Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Diclofenac Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure Indomethacin Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Counter-Irritant Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Fentanyl Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure OTC Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Rx Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Lidocaine Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Diclofenac Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Indomethacin Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Counter-Irritant Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Fentanyl Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure OTC Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Rx Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Lidocaine Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Diclofenac Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Indomethacin Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Counter-Irritant Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Fentanyl Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure OTC Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Rx Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
72.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
73.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
74.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY)
